Aviatrix Automates Cloud Networking Within AWS Control Tower to Ensure Organizations Have a ‘Well-Architected’ Network Topology
25.8.2020 16:00:00 EEST | Business Wire | Press release
Aviatrix, the cloud network platform, today announced new capabilities to automate enterprise network infrastructure deployment and operations for organizations using the account factory feature of AWS Control Tower. Available now in AWS Marketplace, the integrated Aviatrix software serves as the network factory for newly provisioned accounts on Amazon Web Services (AWS). The solution helps enterprise organizations meet cloud governance and regulatory initiatives for their multi-account, multi-region cloud networks.
Join experts from Aviatrix and AWS on Thursday, August 27th as they host a live, online session to highlight the new AWS Control Tower and Aviatrix network factory capabilities. For more information or to register, go here.
“With AWS Control Tower, it only takes a few clicks for enterprise organizations to provision new AWS accounts that conform to company-wide policies,” said Chris Grusz, Director, AWS Marketplace, Amazon Web Services, Inc. “The Aviatrix cloud networking solution uniquely offers a network factory for AWS Control Tower. With AWS Control Tower account factory ensuring account control governance, customers will benefit from Aviatrix’s new capabilities that make certain the network infrastructure supporting those accounts is secure and correctly deployed every time.”
AWS Control Tower provides the easiest way to set up and govern new, secure, multi-account AWS environments. Additionally, AWS Service Catalog enables organizations to create and manage catalogs of approved IT services for use on AWS. The Aviatrix cloud network platform provides the prescriptive transit network architecture and operational visibility that meets enterprise cloud networking and security requirements. The Aviatrix software is able to create Amazon Virtual Private Clouds (Amazon VPCs), automate route table updates and ensure network correctness by preventing overlapping CIDRs, while also enforcing IT security controls through policy-based network segmentation. The integrated solution enables self-service delivery of new account infrastructure, provides detailed operational visibility, and helps ensure IT networking and security teams achieve compliance through a simple, automated workflow.
“In the journey to leverage cloud-based infrastructure we are always on the lookout for ways to streamline the automated delivery of services, in the simplest, most secure manner,” said Justin Donohoo, CTO at Observian. “The Aviatrix cloud network platform delivers the network architecture, advanced network, security controls, and operational visibility enterprises need. I view the integration of Aviatrix with AWS Control Tower as a natural evolution to streamline the delivery of new AWS infrastructure. Leveraging Aviatrix as the network factory and the AWS Control Tower account factory ensures that both AWS accounts and enterprise network infrastructure are deployed correctly and in compliance with corporate policies and industry regulations.”
Provisioning cloud network services is often easier than operationalizing them. AWS Control Tower customers who need to be in full control of their cloud network environment can also use the Aviatrix software to access the network intelligence they need – all in one place – instead of logging into multiple screens, services and management consoles to stitch together the network visibility they require. Aviatrix CoPilot – an available component of the integrated solution for AWS Control Tower - provides a global view of the cloud environment by leveraging intelligence and analytics from the Aviatrix cloud network platform combined with telemetry and network information gathered using native AWS APIs. CoPilot’s rich, intuitive visualizations provide actionable insights to practitioners by using dynamic multi-cloud topology maps, FlowIQ intelligent traffic flow analytics, global traffic heat maps, time series trend charts and a complete cloud network monitoring dashboard.
“AWS Control Tower is a leap forward for enterprise IT teams who are tasked with maintaining control over their networks, without becoming a bottleneck to their organization’s cloud agility and speed,” said Nauman Mustafa, VP of Solution Engineering at Aviatrix. “Regulatory compliance and corporate governance must be automated and adopted for the cloud era. The combination of AWS Control Tower and Aviatrix cloud network platform delivers the simplicity and automation along with enterprise visibility and control.”
Availability and How to Get Started
Aviatrix cloud network platform for AWS Control Tower is available immediately in AWS Marketplace. More technical information on the integrated solution - including how to get started - is available here. For a live demo or further information, please email info@aviatrix.com
About Aviatrix
Aviatrix cloud network platform delivers advanced networking, security and operational visibility required by enterprises with the simplicity and automation of cloud. More than 400 customers worldwide leverage Aviatrix and its proven multi-cloud network reference architecture to design, deploy and operate a repeatable network and security architecture that is consistent across any public cloud. Combined with the industry’s first and only multi-cloud networking certification (ACE), Aviatrix is empowering IT to lead and accelerate the transformation to the cloud. Learn more at Aviatrix.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200825005365/en/
Contact information
Aviatrix
Frank Cabri
frank@aviatrix.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
